Wise Medical Enters the Skin Whitening and Rejuvenation Market with 'Light-Pico Synergy' Integrated Solution, Unlocking a New Path for Efficient Brightening
VISHEE
Developer, Manufacturer, and Distributor of Rehabilitation Medical Devices
VISHEE Enters the Medical Aesthetics Track
As medical aesthetics consumption continues to upgrade, consumers are more willing to choose targeted treatments and products based on their needs. Among medical aesthetic procedures, anti-aging and firming are the most sought-after beauty demands.Skin whitening and rejuvenation follows closely.Although the skin-whitening market continues to expand, issues such as homogenized competition and unclear market positioning have consistently constrained its in-depth development.
By the end of 2025, VISHEE, a STAR Market listed company, officially announced its entry into the skin whitening and rejuvenation track in an investor interaction.Introducing the "Light-Second Synergy" treatment concept through two new products: the Pico V picosecond laser and the VLumina intense pulsed light device., attempting to carve out a differentiated path in a highly competitive market. This strategic move also marks VISHEE's official expansion from the intimacy and body sculpting sectors into the mainstream medical aesthetics track.
From the perspective of industry fundamentals, the market potential and competitive chaos coexist in the whitening and skin rejuvenation track. The "Discovering Healthy New Consumption - Tencent 2024 Annual Light Medical Aesthetics Consumer Trend White Paper" pointed out that consumer demand is extending from facial care to full-body treatments.Full-Body Photon Skin Rejuvenation Becomes an Emerging Popular Category, This trend provides new market opportunities for equipment companies with technological advantages. But at the same time, competition in the whitening sector has entered a feverish stage: imported brands dominate the high-end market due to their first-mover technological advantage, while domestic brands are trapped in price wars in the mid-to-low-end market, with problems such as product homogenization and insufficient innovation becoming prominent. More critically, compared to the anti-aging sector, the independent growth space of the whitening sector has been squeezed over the long term—new technologies like regenerative materials and collagen have drawn more companies to focus on the anti-aging market. Meanwhile, whitening demand, due to its mature development in cosmetics and skincare products, along with the additional benefits provided by procedures like hydradermabrasion and phototherapy, is often regarded by many medical aesthetics institutions as an "ancillary business" rather than a core operational segment.
Against this backdrop, VISHEE's entry into the market reflects strategic considerations. As a national-level specialized and innovative "little giant" enterprise established in 2001, VISHEE has built a strong foundation in rehabilitation devices, accumulating deep technological and channel advantages in areas such as pelvic floor and postpartum rehabilitation, as well as neurorehabilitation. Its core strategy revolves around "focusing on rehabilitation as the cornerstone, while developing emerging businesses in medical aesthetics and urology." This move into the skin whitening and rejuvenation track marks its latest strategic step.It is an important extension of its strategic layout in the medical aesthetics sector, as well as a secondary utilization of the company's technical platform.
Relying on the established technology platforms for energy sources such as lasers and radiofrequency, VISHEE has successfully developed two products for skin whitening and rejuvenation scenarios——Pico V Picosecond Laser, VLumina Intense Pulsed Light Therapy Device, achieving technological migration from rehabilitation medicine to the medical aesthetics field. In terms of product layout, the two new products demonstrate a clear functional complementarity: the Pico V picosecond laser focuses on fading pigmentation and tattoo removal, while the VLumina intense pulsed light therapy device (trade name "Master Light") targets red blood vessel improvement, pore enlargement repair, and other basic skin rejuvenation needs. Together, they comprehensively cover clinical scenarios for whitening and skin rejuvenation.
"Light-second Synergy" is VISHEE's competitive edge in the skin whitening and rejuvenation market.This concept emphasizes the deep synergy and complementary advantages of picosecond and photon technologies: achieving large-area, fundamental skin texture improvement and brightening complexion through photon technology, and then precisely targeting deep pigmentation issues with picosecond lasers, formingBasic Maintenance + Precision RepairOne-stop whitening solution.
In terms of clinical value, this solution not only enhances the diagnostic efficiency and comprehensive service capabilities of medical aesthetic institutions but also optimizes the end-user experience, aligning with the trend of efficient and convenient consumption in lightweight medical aesthetics. From the perspective of product technical details, the approval and market launch of VLumina Master Light (registration number: Su Medical Device Approval No. 20252092190) further highlight its targeted technological breakthroughs.Handpieces Customized for Full-Body Care Can Cover Large Areas of the Body, Precisely Meeting the Market Demand for Whole-Body Whitening; The combination of VMotion dynamic therapy mode and VFree stent solves the pain points of cumbersome operation and low efficiency in large-scale treatment with traditional equipment; the integration of a 16-professional filter system not only addresses various skin issues but also simultaneously achieves triple-effect treatment for pigmentation, vascular concerns, and anti-aging, broadening the application boundaries of the product.
Despite the innovative technical concept, VISHEE's breakthrough in the skin whitening and rejuvenation trackStill facing multiple challenges.First, there is the pressure of homogenized competition. Without establishing a core technology barrier, the concept of "light-second synergy" could easily fall into the trap of "conceptual hype," ultimately being forced into price wars. Second, there is the difficulty of reconstructing track cognition—how to get medical aesthetic institutions and consumers to recognize the value of whitening as an independent track rather than as an add-on to anti-aging services—this will require long-term market education and business model validation. From the perspective of the company itself, while VISHEE has a technological synergy advantage in crossing over from rehabilitation equipment to the medical aesthetics field, the channel logic and marketing models of the medical aesthetics market differ significantly from those of rehabilitation medicine. Whether its existing channel resources can be effectively reused will directly impact the market promotion efficiency of new products.
For VISHEE, entering the whitening and skin-refining track this time is both an opportunity and a challenge. VISHEE's advantages lie in its deep technical accumulation, complete technical platform, and clear differentiated positioning. A 150-person R&D team provides solid support for technological iteration, and the capital advantage of being a STAR Market-listed company can also ensure long-term R&D investment.But to achieve the goal of cultivating medical aesthetics as the second growth curve, multiple thresholds need to be crossed:1. Strengthen technical barriers by validating the therapeutic advantages of the "Light-Second Synergy" solution through clinical data, forming a core competitiveness that is difficult to replicate; 2. Optimize channel layout by building a sales network and cooperation model suitable for the medical aesthetics market, thereby rapidly achieving product market penetration; 3. Reassess the value of the whitening track, making the "Light-Second Synergy" solution an important profit point for medical aesthetic institutions rather than an ancillary service.
Overall, VISHEE's entry into the skin whitening and rejuvenation market is not only a crucial step for the company to expand into the mainstream medical aesthetics market, but also an important attempt by domestically-produced medical device enterprises to advance into the mainstream medical aesthetics sector.
In the face of market opportunities worth hundreds of billions, pain points such as homogenized competition and vague value perception in the skin whitening and rejuvenation sector are in urgent need of resolution. Technological innovation is precisely the key to breaking through this bottleneck, which also gives VISHEE's entry into the industry a demonstrative significance. Whether VISHEE can successfully break through in the medical aesthetics circle hinges not only on the continuous iteration and efficacy validation of its "light-second synergy" technology but also on whether it can transform technological advantages into market advantages. At the same time, it needs to reshape the independent value of the whitening track through effective market education.Its exploration process will provide valuable experience for more Chinese enterprises in the transformation and upgrading within the medical aesthetics field.In the future, VISHEE plans to build a cross-field product series, multi-angle aesthetic strategies, and a multi-scenario commercial system, showcasing the profound strength of Chinese manufacturing from various dimensions. As an emerging force in the medical aesthetics field, every breakthrough and innovation by VISHEE deserves the industry's attention and anticipation.
